Insider Stock Trading History of Collinson Stuart J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Collinson Stuart J since year 2005. The trader's CIK number is 1197037. At the time of this reporting, Collinson Stuart J is the Director of Vertex Pharmaceuticals Inc / Ma . (stock ticker symbol VRTX). See this page for all insider trading activities at Vertex Pharmaceuticals Inc / Ma .


Stock purchases, sales, and option exercises reported by insider Collinson Stuart J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2006-12-14 VRTX Vertex Pharmaceuticals Inc / Ma Sale 50,019 37.81 1,891,218
2006-12-14 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 50,019 13.96 698,515
2006-08-02 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 30,000 9.68 290,400
2006-08-02 VRTX Vertex Pharmaceuticals Inc / Ma Sale 30,000 32.62 978,599
2006-07-03 VRTX Vertex Pharmaceuticals Inc / Ma Sale 30,000 35.84 1,075,200
2006-07-03 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 30,000 9.68 290,400
2006-06-02 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 30,000 9.68 290,400
2006-06-02 VRTX Vertex Pharmaceuticals Inc / Ma Sale 30,000 34.76 1,042,799
2006-05-02 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 30,000 9.68 290,400
2006-05-02 VRTX Vertex Pharmaceuticals Inc / Ma Sale 30,000 34.81 1,044,300
2006-04-03 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 30,000 9.68 290,400
2006-04-03 VRTX Vertex Pharmaceuticals Inc / Ma Sale 30,000 36.11 1,083,300
2006-03-02 VRTX Vertex Pharmaceuticals Inc / Ma Option Ex 30,000 9.68 290,400
2006-03-02 VRTX Vertex Pharmaceuticals Inc / Ma Sale 30,000 43.64 1,309,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Collinson Stuart J (Director of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.